Literature DB >> 9605951

Increased mRNA expression of a novel prostacyclin-stimulating factor in human colon cancer.

F Umeda1, Y Ono, N Sekiguchi, T Hashimoto, M Masakado, K Nakamura, Y Chijiiwa, H Nawata.   

Abstract

We recently cloned a prostacyclin (PGl2)-stimulating factor (PSF), which stimulates PGl2 production by cultured vascular endothelial cells. Immunohistochemistry and Northern blot analysis demonstrated that PSF was highly expressed in colon cancer sites compared with normal colon mucosa obtained from the same patient, as well as in cultured adenocarcinoma cell lines compared with cultured normal colon mucosal cell lines. Increased levels of the PSF protein were detected in the culture media of these adenocarcinoma cells compared with levels in the culture media of normal mucosal cells. These results suggest that PSF is closely associated with carcinogenesis of colon mucosa.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605951     DOI: 10.1007/s005350050072

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  4 in total

1.  Retinal expression, regulation, and functional bioactivity of prostacyclin-stimulating factor.

Authors:  Y Hata; A Clermont; T Yamauchi; E A Pierce; I Suzuma; H Kagokawa; H Yoshikawa; G S Robinson; T Ishibashi; T Hashimoto; F Umeda; S E Bursell; L P Aiello
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  Decreased expression of insulin-like growth factor binding protein 7 in human colorectal carcinoma is related to DNA methylation.

Authors:  Fei Ye; Yuan Chen; Thomas Knösel; Karsten Schlüns; Manuela Pacyna-Gengelbach; Nicole Deutschmann; Maode Lai; Iver Petersen
Journal:  J Cancer Res Clin Oncol       Date:  2006-11-28       Impact factor: 4.553

3.  IGFBP7 is associated with poor prognosis in oesophageal adenocarcinoma and is regulated by promoter DNA methylation.

Authors:  E Smith; A R Ruszkiewicz; G G Jamieson; P A Drew
Journal:  Br J Cancer       Date:  2013-12-19       Impact factor: 7.640

4.  Low levels of IGFBP7 expression in high-grade serous ovarian carcinoma is associated with patient outcome.

Authors:  Karen Gambaro; Michael C J Quinn; Katia Y Cáceres-Gorriti; Rebecca S Shapiro; Diane Provencher; Kurosh Rahimi; Anne-Marie Mes-Masson; Patricia N Tonin
Journal:  BMC Cancer       Date:  2015-03-17       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.